lung cancer

News

Novelos Therapeutics Pivotal Phase 3 Lung Cancer Trial Does Not Meet the Primary Survival Endpoint

Marketwatch

»

Login or register to post comments

News

Zactima’s FDA Application withdrawn (NASDAQ:AZN)

favstocks.com

»

Login or register to post comments

News

Novelos Therapeutics Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial

Trading Markets

»

Login or register to post comments

News

Pfizer Stops Cancer Trial as Survival Didn’t Improve

Bloomberg

»

Login or register to post comments

News

Lilly to Benefit from OSI Rejection

Seeking Alpha

»

Login or register to post comments

News

Novelos CEO: Very Bullish About Upcoming Pivotal Phase III Results

Seeking Alpha

»

Login or register to post comments

News

Panel Rejects Early Use of Tarceva

WSJ Online

»

Login or register to post comments

News

FDA says OSI drug effective against lung cancer

Yahoo/AP

»

Login or register to post comments

News

Oxigene's developing cancer treatment meets safety goals in midstage study

Yahoo/AP

»

Login or register to post comments

News

AstraZeneca pulls Zactima combination submission

Marketwatch

»

Login or register to post comments